There has been a recent resurgence of interest in psychedelic drugs' potential to address conditions like anxiety and depression. That research seems to be leading to the development of new and novel prescription drugs. Illicit drugs like mushrooms, ecstasy, and ketamine are inspiring a range of potential treatments for diseases that currently lack good medications. Like a May shower, the studies on psychedelic drugs' potential therapeutic benefits came — first as a sprinkle, then a steady downpour.